Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Biagioni

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Cancer Letters|August 7, 2023
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugsElena Andreucci, Alessio Biagioni, Sara Peri, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 10, 2025
PHGDH drives 5-FU chemoresistance in colorectal cancer through the Hedgehog signalingCaterina Mancini, Giulia Lori, Gianluca Mattei, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Cancer Letters|August 7, 2023
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugsElena Andreucci, Alessio Biagioni, Sara Peri, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 10, 2025
PHGDH drives 5-FU chemoresistance in colorectal cancer through the Hedgehog signalingCaterina Mancini, Giulia Lori, Gianluca Mattei, et al.
Pageof 6